BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/26/2019 9:58:13 AM | Browse: 153 | Download: 116
Publication Name World Journal of Meta-Analysis
Manuscript ID 50361
Country/Territory United States
2019-08-09 14:57
Peer-Review Started
2019-08-09 14:57
To Make the First Decision
2019-09-27 00:18
Return for Revision
2019-09-30 06:58
2019-10-03 16:40
Second Decision
2019-10-18 10:24
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-10-19 22:16
Articles in Press
2019-10-19 22:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-10-26 00:13
Publish the Manuscript Online
2019-12-02 06:57
ISSN 2308-3840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research and Experimental
Manuscript Type Review
Article Title Treatment of Early Stage (T1) Esophageal Adenocarcinoma: Personalizing the best therapy choice
Manuscript Source Unsolicited Manuscript
All Author List Lindsay Danielle Kumble, Elisabeth Silver, Aaron Oh, Julian A. Abrams, Joshua R Sonett and Chin Hur
Funding Agency and Grant Number
Corresponding author Chin Hur, MD, Doctor, Department of Medicine, Columbia University Irving Medical Center, Columbia University Irving Medical Center, 622 W. 168th St., Presbyterian Hospital 9‐105, New York, NY 10032, United States. ch447@cumc.columbia.edu
Keywords Esophageal cancer; Adenocarcinoma; T1b; Esophagectomy; Endoscopic resection; Chemoradiotherapy
Core Tip This paper is an important source of information for patients and clinicians faced with a diagnosis of T1b esophageal adenocarcinoma (T1b EAC). This paper explores and then outlines the potential benefits and risks of the numerous treatment options for T1b EAC, highlighting the integral role a patient’s individual wishes and values play into making a treatment decision that achieves the greatest outcome for that patient. The review advocates for further research regarding the effects of T1b EAC treatment options on a patient’s quality of life.
Publish Date 2019-12-02 06:57
Citation Kumble LD, Silver E, Oh A, Abrams JA, Sonett JR, Hur C. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World J Meta-Anal 2019; 7(9): 406-417
Url https://www.wjgnet.com/2308-3840/full/v7/i9/406.htm
DOI https://dx.doi.org/10.13105/wjma.v7.i9.406
Full Article (PDF) WJMA-7-406.pdf
Full Article (Word) WJMA-7-406.docx
Manuscript File 50361-Review.docx
Answering Reviewers 50361-Answering reviewers.pdf
Audio Core Tip 50361-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 50361-Conflict-of-interest statement.pdf
Copyright License Agreement 50361-Copyright license agreement.pdf
Peer-review Report 50361-Peer-review(s).pdf
Scientific Misconduct Check 50361-Scientific misconduct check.pdf
Scientific Editor Work List 50361-Scientific editor work list.pdf